ArticlePediatric transplantation2025

Donor-Derived Cell-Free DNA as a Marker for the Efficacy of Daratumumab in Patients With Antibody-Mediated Rejection Post-Heart Transplantation: A Case Series.

Anusha Konduri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.